Paper Details

  1. Home
  2. Paper Details

Oxcarbazepine add-on for drug-resistant focal epilepsy.

Author: Atim-OlukMargaret, BresnahanRebecca, MarsonAnthony G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Epilepsy, a disorder causing seizures, is difficult to control in about 30% of patients, requiring multiple medications. This study explores the use of oxcarbazepine, a medication related to another common anti-seizure drug, as an additional treatment for people with epilepsy who don't respond well to existing medications.
Paper Details　
Original Abstract of the Article :
Epilepsy is a common neurological disorder. In approximately 30% of epilepsy cases, seizures are uncontrolled by one antiepileptic drug (AED). These people require treatment with a combination of multiple AEDs and are described as having drug-resistant epilepsy. Oxcarbazepine is a keto-analogue of c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059897/

データ提供：米国国立医学図書館（NLM）

Oxcarbazepine: A Potential Oasis in the Desert of Drug-Resistant Epilepsy

Epilepsy is a chronic neurological disorder, and for some individuals, seizures are difficult to control with traditional medications. This study explores the potential benefits of adding oxcarbazepine, a keto-analogue of carbamazepine, as an adjunctive treatment for drug-resistant focal epilepsy. The authors discuss the potential benefits and considerations of using oxcarbazepine in this context.

Oxcarbazepine: A New Path Through the Desert of Drug-Resistant Epilepsy

The study explores the role of oxcarbazepine as an adjunctive treatment for drug-resistant focal epilepsy, suggesting a potential new path for managing this challenging condition. The authors highlight the potential benefits of oxcarbazepine as a treatment option for individuals who have not responded well to other antiepileptic drugs.

Navigating the Desert of Epilepsy Management: A New Approach to Drug-Resistant Seizures

This research is a crucial step towards understanding the potential of oxcarbazepine in treating drug-resistant focal epilepsy. The authors' discussion of this new approach provides valuable insights for physicians and patients navigating the challenging landscape of epilepsy management.

Dr. Camel's Conclusion

Drug-resistant epilepsy can be a challenging condition, but this study offers a potential oasis of hope. Oxcarbazepine may provide an effective adjunctive treatment option for individuals who have not responded well to other antiepileptic drugs. This research is a vital step towards improving the lives of those struggling with this chronic neurological disorder.

Date :
  1. Date Completed 2020-08-26
  2. Date Revised 2022-09-14
Further Info :

Pubmed ID

32129501

DOI: Digital Object Identifier

PMC7059897

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.